Inhibition of the JAK-STAT Pathway in the Treatment of Psoriasis: A Review of the Literature
AR Furtunescu, SR Georgescu, M Tampa… - International Journal of …, 2024 - mdpi.com
Psoriasis is a highly prevalent dermatological disease associated with an increased
systemic inflammatory response. In addition, joint involvement is also present in around 20 …
systemic inflammatory response. In addition, joint involvement is also present in around 20 …
Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments
F Zhao, J Zhao, K Wei, P Jiang, Y Shi… - ImmunoTargets and …, 2024 - Taylor & Francis
Psoriasis is a chronic inflammatory skin disease characterized by the excessive proliferation
of keratinocytes and heightened immune activation. Targeting pathogenic genes through …
of keratinocytes and heightened immune activation. Targeting pathogenic genes through …
Treatment of Chronic Plaque Psoriasis: An Overview on Current Update
Introduction Chronic plaque psoriasis is an inflammatory skin disorder that affects 2% to 3%
of the population. The severity of the disease is influenced by the number and location of …
of the population. The severity of the disease is influenced by the number and location of …
Comparison of the Efficacy of Tazarotene 0.045% versus Halobetasol Propionate 0.01% Lotion for the Treatment of Scalp Psoriasis at Tertiary Care Hospital, Karachi
N Jabeen, R Ghafoor, K Asadullah, P Sanawar… - Journal of Health and …, 2024 - jhrlmc.com
Background: Psoriasis is a chronic, genetically determined inflammatory skin condition
characterized by erythematous plaques with silvery scales, affecting about 2% of the global …
characterized by erythematous plaques with silvery scales, affecting about 2% of the global …